Reimbursement systems in the Middle East and South Africa are unique and therefore require a tailored approach to meet the needs of the local market.
In these regions the focus lies in selling the need for subsidy to opinion leaders in both the private and public sector. IMS-HEOR have reviewed drug reimbursement systems across this region including countries such as United Arab Emirates and South Africa.